Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (2596)	2/17/2000 6:56:00 PM
From: Walter Morton	Respond to of 2742

PMC has a new name. Aventis Pasteur operated under the Pasteur Merieux Connaught name until the creation of Aventis. Aventis was launched on December 15, 1999 through the merger of Hoechst AG and Rhone-Poulenc SA. Aventis Pasteur is the human vaccines business of Aventis S.A. (NYSE:AVE): quote.yahoo.com

To: Phil Cressman who wrote (2596)	2/17/2000 7:05:00 PM
From: Walter Morton	Respond to of 2742

This alone may be worth $1.50 per share: Message 12753536

To: Phil Cressman who wrote (2596)	2/17/2000 7:09:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

The Duke University deal was originally signed in September 1998: "Duke University ("DUKE") and CISTRON Biotechnology, Inc. ("SPONSOR") agree to amend the terms of the Clinical Study and Research Agreement entered into by the parties effective September 1, 1998..." 10-Q on 02/14/2000 On June 30, 1998, Cistron and Pasteur Merieux Serums & Vaccins, S.A. (PMS&V), the world's largest vaccine company, entered into a letter of intent for an option and license agreement pertaining to the use of IL-1 as a vaccine adjuvant in the fields of preventive and therapeutic vaccines. On October 30, 1998, PMS&V purchased 1,333,333 shares of Cistron common stock at approximately $.75 per share and received warrants to purchase 666,667 additional shares at $.25 per share, for an aggregate price of $1,000,000.